Pharmacopoeial Quality Standards for Radiopharmaceuticals for Positron-Emission Tomography

The current state of quality standards for radiopharmaceuticals (RPs) for positron-emission tomography (PET) is assessed considering primarily national and global requirements for pharmacopoeial practice. The need to develop both general pharmacopoeial standards for RPs for PET and specific monograp...

Full description

Saved in:
Bibliographic Details
Published in:Pharmaceutical chemistry journal 2020-07, Vol.54 (4), p.419-421
Main Authors: Gromakov, A. S., Sakanyan, E. I., Senchenko, S. P., Ruziev, R. D.
Format: Article
Language:English
Subjects:
Medicine
Organic Chemistry
PET imaging
Pets
Pharmacology/Toxicology
Pharmacy
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The current state of quality standards for radiopharmaceuticals (RPs) for positron-emission tomography (PET) is assessed considering primarily national and global requirements for pharmacopoeial practice. The need to develop both general pharmacopoeial standards for RPs for PET and specific monographs for separate pharmaceuticals is established. Common approaches to standardization of each quality indicator are proposed considering known features of PET RPs using dosage forms for parenteral administration as examples.
ISSN:0091-150X
1573-9031
DOI:10.1007/s11094-020-02213-y